Biotechnology VALUE FUND II L.P., 10% Owner at XOMA Corp (XOMA), bought 122,046 shares at $14.54 ($1.8M) on 2018-12-10, disclosed to the SEC on 2018-12-10.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.80 | 10,927 | $162K | 9.0% |
| 2 | $14.80 | 10,927 | $162K | 9.0% |
| 3 | $14.77 | 32,015 | $473K | 26.3% |
| 4 | $14.77 | 32,015 | $473K | 26.3% |
| 5 | $14.54 | 18,081 | $263K | 14.6% |
| 6 | $14.54 | 18,081 |
| $263K |
| 14.6% |
| Total | $14.71 avg | 122,046 | $1.8M | 100% |
| Filing → |
| THRD | BUY | 2022-12-22 | $1.7M | — | Filing → |
| KYMR | BUY | 2022-08-23 | $14.2M | — | Filing → |
| RPTX | BUY | 2022-06-15 | $3.8M | — | Filing → |